Table 3.

The Polymorphisms of the GEMIN4 Gene and the Risk of Prostate Cancer

		Patients (N=300)		Controls (N=244)
Polymorphism		N	%	n	%	OR (95% CI)
	CC	10	3.33	19	7.79	1
	CT	98	32.67	81	33.20	2.29 (0.95, 5.84)
	TT	192	64.00	144	59.02	2.53 (1.07, 6.28)
	C	118	19.67	119	24.39	1
rs7813	T	482	80.33	369	75.61	1.32 (0.98, 1.78)
	TT	259	86.33	201	82.37	1
	TA/AA	41	13.67	43	17.62	0.74 (0.45, 1.21)
	T	559	93.17	445	91.19	1
rs4968104	A	41	6.83	43	8.81	0.76 (0.47, 1.22)
	CC	188	62.67	142	58.20	1
	CT	92	30.67	82	33.61	0.85 (0.58, 1.25)
	TT	20	6.67	20	8.20	0.76 (0.37, 1.54)
	C	468	78.00	366	75.00	1
rs3744741	T	132	22.00	122	25.00	0.85 (0.63, 1.13)
	GG	246	82.00	182	74.60	1
	GC/CC	54	18.00	62	25.40	0.64 (0.42, 0.99)
	G	546	91.00	426	87.30	1
rs2740348	C	54	9.00	62	12.70	0.64 (0.42, 0.99)
	TT	298	99.33	240	98.36	1
	TC/CC	2	0.67	4	1.64	0.40 (0.04, 2.84)
	T	598	99.67	484	99.18	1
rs1062923	C	2	0.33	4	0.82	0.40 (0.04, 2.84)
	CC	23	7.67	18	7.37	1
	CG	135	45.00	103	42.21	1.03 (0.49, 2.10)
	GG	142	47.33	123	50.40	0.90 (0.44, 1.84)
	C	181	30.17	139	28.48	1
rs910925	G	419	69.83	349	71.52	0.92 (0.70, 1.21)
	CC	240	80.00	190	77.87	1
	CT/TT	60	20.00	54	22.13	0.88 (0.57, 1.36)
	C	540	90.00	434	88.93	1
rs910924	T	60	10.00	54	11.07	0.89 (0.59, 1.34)

The bold numbers mean the p-value is <0.05.

OR, odds ratio; CI, confidence interval.